Reported Reactions

Devices › Implant, dermal, for aesthetic use

Device brand name · Implant dermal for aesthetic use

VOLBELLA with LIDOCAINE: medical device reports filed with FDA

641 reports name it, 2016–2026. Manufacturer given most often on reports: Allergan Pringy. Product code LMH.

641
device reports naming the brand
0% of all MAUDE reports · about 64 a year
5
reports, 12 months to August 2026
7 in the 12 months before
11.9%
classified as malfunction
7.2% across the product code
0.2%
classified as death, as reported
1 reports · not verified by FDA

641 medical device reports received by FDA name the brand "VOLBELLA with LIDOCAINE" (implant dermal for aesthetic use); the manufacturer given most often on reports is Allergan Pringy; received from June 2016 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

5 reports arrived in the 12 months to August 2026, down 29% from 7 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (88%), malfunction (11.9%) and death (0.2%); across all implant, dermal, for aesthetic use reports (product code LMH) death is recorded in 0.1% and malfunction in 7.2%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are improper or incorrect procedure or method (4.8%), gel leak (3.7%) and crack (3.3%). The patient problems coded most often are skin irritation, edema and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

035Sep 2021: 4Oct 2021: 5Nov 2021: 1Dec 2021: 12022Jan 2022: 0Feb 2022: 2Mar 2022: 1Apr 2022: 1May 2022: 2Jun 2022: 2Jul 2022: 1Aug 2022: 3Sep 2022: 0Oct 2022: 2Nov 2022: 1Dec 2022: 22023Jan 2023: 0Feb 2023: 0Mar 2023: 1Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 3Aug 2023: 0Sep 2023: 3Oct 2023: 2Nov 2023: 0Dec 2023: 52024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 1May 2024: 0Jun 2024: 2Jul 2024: 0Aug 2024: 0Sep 2024: 0Oct 2024: 0Nov 2024: 1Dec 2024: 02025Jan 2025: 0Feb 2025: 1Mar 2025: 1Apr 2025: 2May 2025: 1Jun 2025: 0Jul 2025: 1Aug 2025: 0Sep 2025: 0Oct 2025: 0Nov 2025: 0Dec 2025: 02026Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 2May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 1

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0911822016: 5520162017: 1492018: 18220182019: 992020: 6620202021: 442022: 1720222023: 142024: 420242025: 62026: 52026

Event type and report source

Event type, as classified on the report

Death0.2%1
Injury88%564
Malfunction11.9%76
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%641
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 22,802 reports carrying product code LMH. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Improper or incorrect procedure or method314.8%7.5%
Gel leak243.7%1.3%
Crackthe device cracked213.3%0.9%
Breakthe device broke193%0.9%
Detachment of device or device componentpart of the device came off172.7%1.9%
Expulsion111.7%1%
Detachment of device component101.6%1.7%
Migration or expulsion of device60.9%0.7%
Migrationthe device moved from where it was placed50.8%0.4%
Off-label use50.8%4.2%
Leak/splashthe device leaked40.6%1%
Difficult or delayed activation30.5%0.2%
Shelf life exceeded30.5%0%
Burst container or vessel20.3%0.3%
Coagulation in device or device ingredient20.3%0.1%
Defective component10.2%0.1%
Delivered as unsterile product10.2%0%
Difficult or delayed positioning10.2%0.2%
Fracturea broken bone10.2%0%
Packaging problem10.2%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Skin irritationirritated skin26341%
Edemaswelling from fluid19430.3%
Inflammationinflammation16826.2%
Painpain, site not specified436.7%
Erythemaskin redness396.1%
Hypersensitivity/allergic reaction365.6%
Vascular system (circulation), impaired274.2%
Granuloma253.9%
Nodule233.6%
Subcutaneous nodule233.6%
Abscessa collection of pus193%
Skin discoloration172.7%
Bruise/contusion121.9%
Skin inflammation111.7%
Viral infectiona viral infection111.7%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureVOLBELLA with LIDOCAINEProduct code LMHAll MAUDE reports
Reports64122,80226,136,888
Share of that pool—2.8%0%
Classified as death, per 1,000 reports219
Classified as injury88%83.7%36.2%
Classified as malfunction11.9%7.2%62.3%
Filed by the manufacturer100%95.3%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code LMH

BrandReportsLatest 12 monthsClassified as death
Sculptra1,593910%
Juvederm Voluma Xc/Lido Volume Unknown1,0471940.1%
Juvederm Voluma XC 27G 2 x 1mL901780%
Juvederm Ultra Xc Tsk Us68110%
Unk Volbella663700%
Juvederm VOLUMA WITH LIDOCAINE 1mL622230%
Radiesse Dermal Filler59600%
Juvederm Volume/Concentration/Additive Unknown502240.6%
Juvederm Ultra Plus Xc Tsk Us49550%
Zyplast Collagen Implant46600%
VOLIFT with LIDOCAINE458100%
Unk Juvederm Volux4451330%
Radiesse Injectable Implant44100%
JUVEDERM VOLLURE XC 2x1 mL427240.5%
Juvederm Voluma Volume/Additive Unknown426130%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about VOLBELLA with LIDOCAINE reports

How many FDA reports name VOLBELLA with LIDOCAINE?

641 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 5 in the latest 12 months.

What kinds of events are reported?

injury (88%), malfunction (11.9%) and death (0.2%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

improper or incorrect procedure or method (4.8%), gel leak (3.7%), crack (3.3%), break (3%) and detachment of device or device component (2.7%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that VOLBELLA with LIDOCAINE was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.